Incidence and characteristics of patients with visual impairment due to macular edema secondary to retinal vein occlusion in a representative Canadian cohort

Journal of Ophthalmology

Volumn 2012, Issue , 2012, Pages

  Petrella, Robert J ^a,b,c   Blouin, Julie ^d   Davies, Brian ^d   Barbeau, Martin ^d  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b Individual Health Outcomes Inc   (Canada)

^c PARKWOOD HOSPITAL   (Canada)

^d Novartis Pharmaceuticals Canada Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873833220     PISSN: 2090004X     EISSN: 20900058     Source Type: Journal    
DOI: 10.1155/2012/723169     Document Type: Article

References (21)

1. Laouri M., Chen E., Looman M., Gallagher M., The burden of disease of retinal vein occlusion: review of the literature. Eye 25 8 981 988
2. Keane P. A., Sadda S. R., Retinal vein occlusion and macular edema-critical evaluation of the clinical value of ranibizumab. Clinical Ophthalmology 2011 5 1 771 781 2-s2.0-79959849101 10.2147/OPTH.S13774
3. Klein R., Klein B. E. K., Moss S. E., Meuer S. M., Gutman F. A., Ferris F. L., Klein R., The epidemiology of retinal vein occlusion: the beaver dam eye study. Transactions of the American Ophthalmological Society 2000 98 133 143 2-s2.0-0034527456 (Pubitemid 32059501)
4. Mitchell P., Smith W., Chang A., Prevalence and associations of retinal vein occlusion in Australia: the blue mountains eye study. Archives of Ophthalmology 1996 114 10 1243 1247 2-s2.0-0029842865 (Pubitemid 26338856)
5. Rogers S., McIntosh R. L., Cheung N., Lim L., Wang J. J., Mitchell P., Kowalski J. W., Nguyen H., Wong T. Y., The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2010 117 2 313 319 2-s2.0-75149172639 10.1016/j.ophtha.2009.07.017
6. Klein R., Moss S. E., Meuer S. M., Klein B. E. K., The 15-year cumulative incidence of retinal vein occlusion. The Beaver Dam Eye Study. Archives of Ophthalmology 2008 126 4 513 518 2-s2.0-42249083700 10.1001/archopht.126.4.513 (Pubitemid 351549845)
7. Karia N., Retinal vein occlusion: pathophysiology and treatment options. Clinical Ophthalmology 2010 4 1 809 816 2-s2.0-77956113448
8. Lattanzio R., Torres Gimeno A., Battaglia Parodi M., Bandello F., Retinal vein occlusion: current treatment. Ophthalmologica 2011 225 3 135 143 2-s2.0-77957728450 10.1159/000314718
9. Battaglia Parodi M., Bandello F., Branch retinal vein occlusion: classification and treatment. Ophthalmologica 2009 223 5 298 305 2-s2.0-64549148797 10.1159/000213640
10. Ho A. C., Ip M. S., Spade R. F., Emerging data on new therapies and treatment paradigms for RVO Treatment. Special Supplement. Retina Today, 2011
11. Cugati S., Wang J. J., Rochtchina E., Mitchell P., Ten-year incidence of retinal vein occlusion in an older population: the blue mountains eye study. Archives of Ophthalmology 2006 124 5 726 732 2-s2.0-33646472759
12. Petrella R. J., Merikle E. P., Jones J., Prevalence, treatment, and control of hypertension in primary care: gaps, trends, and opportunities. Journal of Clinical Hypertension 2007 9 1 28 35 2-s2.0-33847732189
13. Petrella R. J., Merikle E., Jones J., Prevalence and treatment of dyslipidemia in canadian primary care: a retrospective cohort analysis. Clinical Therapeutics 2007 29 4 742 750 2-s2.0-34347378697 10.1016/j.clinthera.2007.04. 009 (Pubitemid 47018270)
14. Petrella R. J., Merikle E., A retrospective analysis of the prevalence and treatment of hypertension and dyslipidemia in Southwestern Ontario, Canada. Clinical Therapeutics 2008 30 6 1145 1154 2-s2.0-47149087397 10.1016/j.clinthera.2008.06.004 (Pubitemid 351978118)
15. Petrella R., Massien C., What is the impact of switching from an ACE inhibitor to an angiotensin receptor blocker on blood pressure and cardiovascular events? Proceedings of the ISPOR 15th Annual International Meeting 2010 Atlanta, Ga, USA
16. Arakawa S., Yasuda M., Nagata M., Nine-year incidence and risk factors for retinal vein occlusion in a general Japanese population: the hisayama study. Investigative Ophthalmology & Visual Science 2011 52 8 5905 5909
17. Hayreh S. S., Zimmerman B., McCarthy M. J., Podhajsky P., Systemic diseases associated with various types of retinal vein occlusion. American Journal of Ophthalmology 2001 131 1 61 77 2-s2.0-0035157973 10.1016/S0002- 9394(00)00709-1 (Pubitemid 32037010)
18. Martin S. C., Butcher A., Martin N., Farmer J., Dobson P. M., Bartlett W. A., Jones A. F., Cardiovascular risk assessment in patients with retinal vein occlusion. British Journal of Ophthalmology 2002 86 7 774 776 2-s2.0-0036298661 10.1136/bjo.86.7.774 (Pubitemid 34713165)
19. O'Mahoney P. R. A., Wong D. T., Ray J. G., Retinal vein occlusion and traditional risk factors for atherosclerosis. Archives of Ophthalmology 2008 126 5 692 699 2-s2.0-43549098827 10.1001/archopht.126.5.692 (Pubitemid 351679566)
20. Yau J. W. Y., Lee P., Wong T. Y., Best J., Jenkins A., Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Internal Medicine Journal 2008 38 12 904 910 2-s2.0-58149196547 10.1111/j.1445-5994.2008.01720.x
21. Bearelly S., Mruthyunjaya P., Jzeng J. P., Suñer I. J., Shea A. M., Lee J. T., Kowalski J. W., Curtis L. H., Schulman K. A., Lee P. P., Identification of patients with diabetic macular edema from claims data: a validation study. Archives of Ophthalmology 2008 126 7 986 989 2-s2.0-47549098479 10.1001/archopht.126.7.986 (Pubitemid 352008384)